Bone-targeting agents in major solid tumour metastases: a multinational cohort study.

Ju Hwan KimChin-Yao ShenPhilip Chun-Ming AuYeon-Hee BaekChing-Lung CheungWei-Pang ChungNora Joelle KleinmanTai Chung LamTzu-Chi LiaoTzu-Chieh LinJu-Young ShinChor-Wing SingIan Chi Kei WongEdward Chia-Cheng Lai

Published in: BMJ supportive & palliative care (2022)

We found the rate of BTA utilisation remained low across all sites and tumour types in recent years. The dynamic utilisation patterns of BTAs provide better understanding of the treatment landscape for future evaluation of associated outcomes of patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
current status
cancer therapy
bone mineral density
single cell
skeletal muscle
adipose tissue
patient reported outcomes
soft tissue
postmenopausal women
body composition